Skip to main content
OpenTrials

Clinical trial condition

Hemoglobinopathies

Explore clinical trials studying Hemoglobinopathies. Study availability and eligibility vary by location and protocol.

48 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Hemoglobinopathies trial results

Enrolling by Invitation

A Long-term Follow-up Study in Participants Who Received CTX001

NCT04208529

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +11 more
Locations
  • Lucile Packard Children's Hospital Palo Alto, California, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago - Hematology Chicago, Illinois, United States
  • Herbert Irving Pavilion - Hematology New York, United States
  • New York Presbyterian Hospital - Morgan Stanley Children's Hospital New York, United States
View all 20 locations
View Trial Details
Enrolling by Invitation

A Long-Term Follow-Up Study of Participants With Sickle Cell Disease or Transfusion Dependent β-Thalassemia Who Received EDIT-301

NCT06363760

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +10 more
Locations
  • UCSF Benioff Children's Hospital Oakland, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Smilow Cancer Hospital New Haven, Connecticut, United States
  • Johns Hopkins All Children's Hospital St. Petersburg, Florida, United States
View all 18 locations
View Trial Details
Completed

A Safety and Efficacy Study Evaluating CTX001 in Participants With Transfusion-Dependent β-Thalassemia

NCT03655678

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +8 more
Locations
  • Lucile Packard Children's Hospital Palo Alto, California, United States
  • Ann & Robert Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • Columbia University Medical Center (21+ years) New York, United States
  • Columbia University Medical Center New York, United States
View all 14 locations
View Trial Details
Completed

A Safety and Efficacy Study Evaluating CTX001 in Subjects With Severe Sickle Cell Disease

NCT03745287

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +8 more
Locations
  • Lucile Packard Children's Hospital of Stanford University Palo Alto, California, United States
  • Ann & Robert Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • University of Illinois at Chicago Hospitals and Health Systems Chicago, Illinois, United States
  • Columbia University Medical Center (21+ years) New York, United States
View all 17 locations
View Trial Details

Related conditions